Palvella Therapeutics (PVLA) EBITDA (2014 - 2024)
Palvella Therapeutics (PVLA) reported EBITDA of -$5.06 million for Q3 2024, compared with -$11.07 million a year earlier.
Powered by 
Analysis
Palvella Therapeutics (PVLA) EBITDA (2014 - 2024) Analysis & Trends
Over the twelve months ended Sep 30, 2024, Palvella Therapeutics' EBITDA came in at $3.43 million; for FY2023, it was -$9.97 million.
- By year, EBITDA came in at -$40.7 million in FY2022, -$49.37 million in FY2021, -$31.61 million in FY2020 and -$26.53 million in FY2019.
- Five-year quarterly EBITDA spans a low of -$18.4 million in Q3 2021 and a high of $13.19 million in Q4 2023.
- Per Business Quant data, the three quarters before Q3 2024 came in at -$2.91 million (Q2 2024), -$1.79 million (Q1 2024) and $13.19 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -5.06 Mn |
| Jun 30, 2024 | -2.91 Mn |
| Mar 31, 2024 | -1.79 Mn |
| Dec 31, 2023 | 13.19 Mn |
| Sep 30, 2023 | -11.07 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | -14.91 Mn |
| Dec 31, 2022 | -10.94 Mn |
| Sep 30, 2022 | -11.40 Mn |
| Jun 30, 2022 | -11.75 Mn |
| Mar 31, 2022 | -6.61 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | -18.40 Mn |
| Jun 30, 2021 | -16.14 Mn |
| Mar 31, 2021 | -4.43 Mn |
| Dec 31, 2020 | -11.72 Mn |
| Sep 30, 2020 | -12.25 Mn |
| Jun 30, 2020 | -4.13 Mn |
| Mar 31, 2020 | -3.52 Mn |
| Dec 31, 2019 | -1.07 Mn |
API Access
Palvella Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();